Safety and Pharmacokinetics of TT30 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)
A Phase 1, Single Ascending Dose Study of the Safety and Pharmacokinetics of TT30 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH) A Phase 1, Single Ascending Dose Study of the Safety and Pharmacokinetics of TT30 in Subjects With P ...
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Drug: ALXN1102;Drug: ALXN1103
Alexion Pharmaceuticals
NULL
Terminated
18 Years
N/A
Both
10
Phase 1
United States;Czech Republic;Italy;Poland;United Kingdom